LEMTRADA (Campath, alemtuzumab)

Pages: [1] 2

Subject / Started by	Replies / Views	Last post
(Abst.) Siponimod following alemtuzumab for SPMS... (Abst.) Siponimod following alemtuzumab for SPMS... agate · August 18, 2024, 11:36:27 am From PubMed (August 18, 2024)--"Siponimod following alemtuzumab for secondary progressive multiple sclerosis: Investigating sequ... 0 Replies · 256 Views Started by agate	0 Replies 256 Views	August 18, 2024, 11:36:27 am by agate
Impact of previous DMT on effectiveness, safety outcomes in PwMS treated w/Lemtrada Impact of previous DMT on effectiveness, safety outcomes in PwMS treated w/Lemtrada agate · April 05, 2021, 03:17:30 pm From the Journal of Neurology, Neurosurgery and Psychiatry (April 5, 2021), "Impact of previous disease-modifying treatment on ... 0 Replies · 321 Views Started by agate	0 Replies 321 Views	April 05, 2021, 03:17:30 pm by agate
(Abst.) Alemtuzumab and rx medication use in the MS population (Abst.) Alemtuzumab and rx medication use in the MS population agate · May 14, 2020, 10:01:41 am This study indicates that people with MS taking alemtuzumab are also highly likely to be taking quite a few prescription drugs. ... 0 Replies · 317 Views Started by agate	0 Replies 317 Views	May 14, 2020, 10:01:41 am by agate
(Abst.) Acute cardiotoxicity associated w/alemtuzumab infusion for MS (Abst.) Acute cardiotoxicity associated w/alemtuzumab infusion for MS agate · April 20, 2020, 08:29:55 am From Multiple Sclerosis Journal (April 20, 2020)--"Acute cardiotoxicity associated with alemtuzumab infusion for multiple sclero... 0 Replies · 343 Views Started by agate	0 Replies 343 Views	April 20, 2020, 08:29:55 am by agate
(ACTRIMS) Fatal intercerebral hemorrhage secondary to alemtuzumab (ACTRIMS) Fatal intercerebral hemorrhage secondary to alemtuzumab agate · March 14, 2020, 03:06:02 pm Abstract of a paper presented at the recent (February 27-29) ACTRIMS conference, entitled "Fatal intercerebral hemorrhage second... 0 Replies · 359 Views Started by agate	0 Replies 359 Views	March 14, 2020, 03:06:02 pm by agate
(Abst.) ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for MS (Abst.) ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for MS agate · February 23, 2020, 03:20:27 pm From PubMed (February 23, 2020), "ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple ... 0 Replies · 353 Views Started by agate	0 Replies 353 Views	February 23, 2020, 03:20:27 pm by agate
Refractory chronic spontaneous urticaria after Lemtrada in MS Refractory chronic spontaneous urticaria after Lemtrada in MS agate · January 10, 2020, 09:18:32 pm This is the entire (short) article in Neurology (January 2020) by researchers in Australia--entitled "Refractory chronic spontan... 0 Replies · 231 Views Started by agate	0 Replies 231 Views	January 10, 2020, 09:18:32 pm by agate
(Abst.) Alemtuzumab-induced lung injury in 3 MS patients (Abst.) Alemtuzumab-induced lung injury in 3 MS patients agate · November 03, 2019, 07:27:43 pm From PubMed (November 2, 2019), "Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patient... 0 Replies · 274 Views Started by agate	0 Replies 274 Views	November 03, 2019, 07:27:43 pm by agate
(MS Journal editorial) Emerging safety issues in alemtuzumab-treated MS patients (MS Journal editorial) Emerging safety issues in alemtuzumab-treated MS patients agate · August 02, 2019, 02:55:41 pm An editorial with cautions about Lemtrada--"Emerging safety issues in alemtuzumab-treated MS patients" in Multiple Sclerosis Jou... 0 Replies · 280 Views Started by agate	0 Replies 280 Views	August 02, 2019, 02:55:41 pm by agate
EMA to restrict use of alemtuzumab pending review EMA to restrict use of alemtuzumab pending review agate · May 14, 2019, 04:34:57 pm The concern about stroke risk has prompted the European Medicines Agency to restrict the use of alemtuzumab pending review. From... 0 Replies · 264 Views Started by agate	0 Replies 264 Views	May 14, 2019, 04:34:57 pm by agate
Alemtuzumab under scrutiny because of risk of stroke in some patients with MS Alemtuzumab under scrutiny because of risk of stroke in some patients with MS agate · April 26, 2019, 07:15:37 am The Lancet (April 27, 2019) contains an article on this topic though there is no easy access to it. However, another article (fr... 0 Replies · 375 Views Started by agate	0 Replies 375 Views	April 26, 2019, 07:15:37 am by agate
(Abst.) Autoimmune nephropathies after Lemtrada treatment in PwMS (Abst.) Autoimmune nephropathies after Lemtrada treatment in PwMS agate · April 22, 2019, 02:42:03 pm From Multiple Sclerosis Journal (April 15, 2019), "Incidence, management, and outcomes of autoimmune nephropathies following ale... 0 Replies · 270 Views Started by agate	0 Replies 270 Views	April 22, 2019, 02:42:03 pm by agate
(Abst.) Immune profiling of a patient w/alemtuzumab-associated PML (Abst.) Immune profiling of a patient w/alemtuzumab-associated PML agate · April 10, 2019, 04:24:57 pm From PubMed (April 10, 2019), "Immune profiling of a patient w/alemtuzumab-associated PML": http://bit.ly/2IdR0WO 0 Replies · 291 Views Started by agate	0 Replies 291 Views	April 10, 2019, 04:24:57 pm by agate
(Abst.) Neutropenia w/fatal outcome in MS patient 23 days after alemtuzumab infusion (Abst.) Neutropenia w/fatal outcome in MS patient 23 days after alemtuzumab infusion agate · July 23, 2018, 07:49:08 pm From Multiple Sclerosis and Related Disorders (July 2018), "Neutropenia with fatal outcome in a multiple sclerosis patient 23 da... 0 Replies · 367 Views Started by agate	0 Replies 367 Views	July 23, 2018, 07:49:08 pm by agate
More risks emerge for alemtuzumab in MS More risks emerge for alemtuzumab in MS agate · April 08, 2018, 04:27:28 pm From MedPage Today, "More risks emerge for alemtuzumab in MS" (April 6, 2018):[url]https://www.medpagetoday.com/neurology/multip... 0 Replies · 291 Views Started by agate	0 Replies 291 Views	April 08, 2018, 04:27:28 pm by agate
(Absts.) Two adverse events with Lemtrada reported (Absts.) Two adverse events with Lemtrada reported agate · January 29, 2018, 06:40:19 pm From Multiple Sclerosis Journal, January 23, 2018--"Life-threatening autoimmune warm hemolytic anemia following treatment for mu... 0 Replies · 413 Views Started by agate	0 Replies 413 Views	January 29, 2018, 06:40:19 pm by agate
(Abst.) Decreased platelet number in MS during alemtuzumab infusion... (Abst.) Decreased platelet number in MS during alemtuzumab infusion... agate · January 25, 2018, 04:31:23 pm "Decreased platelet number in multiple sclerosis during alemtuzumab infusion: A common, transient, and clinically silent phenome... 0 Replies · 359 Views Started by agate	0 Replies 359 Views	January 25, 2018, 04:31:23 pm by agate
(Abst.) Activation of MS during Lemtrada therapy in 3 patients w/MS (Abst.) Activation of MS during Lemtrada therapy in 3 patients w/MS agate · January 21, 2018, 03:41:12 pm From PubMed (January 21, 2018)-- "Activation of disease during therapy with alemtuzumab in 3 patients with multiple sclerosis":h... 0 Replies · 336 Views Started by agate	0 Replies 336 Views	January 21, 2018, 03:41:12 pm by agate
(Abst.) Alemtuzumab in MS: Lessons from social media in enhancing patient care (Abst.) Alemtuzumab in MS: Lessons from social media in enhancing patient care agate · December 23, 2017, 08:57:09 am From PubMed, December 23, 2017:QuoteInt J MS Care. 2017 Nov-Dec;19(6):323-328. Alemtuzumab in Multiple Sclerosis: Lessons from S... 0 Replies · 393 Views Started by agate	0 Replies 393 Views	December 23, 2017, 08:57:09 am by agate
Induction of new autoimmune diseases after alemtuzumab therapy for MS: Learning from adversity Induction of new autoimmune diseases after alemtuzumab therapy for MS: Learning from adversity agate · June 12, 2017, 08:40:12 pm An editorial in JAMA Neurology, June 12, 2017, seems to be trying to find something positive about the diseases like PML that cr... 0 Replies · 336 Views Started by agate	0 Replies 336 Views	June 12, 2017, 08:40:12 pm by agate

Pages: [1] 2

Normal Topic
Hot Topic (More than 15 replies)
Very Hot Topic (More than 1 replies)

Locked Topic
Sticky Topic
Poll

MS Speaks